Efforts by the Swiss Medtech industry association to secure less onerous labeling rules for medtech products entering the Swiss market, now that the country’s EU mutual recognition agreement no longer applies, have paid off.
At the end of 2021, the association reached what it describes as a “suitable” agreement with the Federal Office of Public Health (FOPH) and the Swissmedic regulatory authority on a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?